untitled
|
|
|
- つかさ あみおか
- 7 years ago
- Views:
Transcription
1 Aesthetic Surg J 2006; 26: Gottfried Lemperle, MD, PhD, San Diego, CA David M. Duffy, MD, Los Angeles, CA. Zyderm, Inamed, Santa Barbara, CA Restylane Fine Line, Q-Med, Uppsala, Sweden Sculptra, Sanofi-Aventis, Paris, FR L-Sculptra Radiesse, Bioform Medical, San Mateo, CA HEMA Dermalive, Dermatech, Paris, France Silikon 1000, Alcon Laboratories, Fort Worth, TX SilSkin RJ Development, Chester, MO AdatoSil 5000 Chiron, Emeryville, CA PMMA ArteFill, Artes Medical, San Diego, CA Aquamid, Ferrosan NS, Copenhagen, Denmark Bio-Alcamid Polymekon, Milan, Italy 1
2 1 HIV 1 mm mm Radiesse, Sculptra ArteFill 2
3 2 IU Botox Allergan, Inc., Irvine, CA 3 Velcro Velcro Industries, Manchester, NH IPL Kenalog, Bristol Myers Squibb, N. Billerca, MA Diprosone, Schering Plough, Kenilworth, NJDepo-Medrol, Pharmacia & Upjohn, Kalamazoo, MI
4 1 3 Botox 4 Velcro shave sculpting shave sculpting 3 Sculptra ArteFill 5 Radiesse 1 2 Radiesse 6, Sculptra Dermalive 3 ArteFill 3 3 Kenalog Zyplast Inamed, Santa Barbara, CA 5 Inamed Zyplast Zyderm 4
5 Zyplast Zyplast 1. Zyderm 2. 5
6 3. 4. Sculptra
7 5. A Zyplast B IPL Saylan Restylane
8 Sculptra mg 7 Voy Mohasseb 10 André 11 HIV 5 Restylane New-Fill Profill OV SA-France 9 Voy André 6. Artecoll 1 8
9 7. A B 3. 7 Zyderm, 6 >5,000, :300 1:2500 Zyplast >2,000, :250 1:2,600 Restylane PLA >12 >150, :400 1:500 Sculptra/New-Fill ml Ca-HA >12 >150, <1:50,000 Radiance/Radiesse 2004 HEMA >12 >170, :80 1:450 Dermalive 2003 PMMA Artecoll >400, :800 1:5, cs Aquamid, Bio-Alcamid >400, >200, :900 >1:1,000 1:300 1:5000 9
10 8. A Zyderm I B Artecoll 10
11 4. Kenalog; Volon-A, Germany Diprosone Depo-Medrol Diprosone 3.5 mg +5-FU 80 mg Kenalog 5FU mg 5 7 mg mg 0.5 ml+1.6 ml+1 ml 10 mg/ml +5-FU 50 mg/ml 9. 6 Dermalive 10 m 20 m mm
12 , 7 Carruthers T Kenalog 1, 7 Bleomycin Bristol-Myers Squibb, New York, NYIsotretinoin Barr Pharmaceuticals, Pomona, NY Imuran Glaxo Wellcome, Auckland, New Zealand Aldara 3M, St. Paul, MN mg/ml Kenalog blanching 40 mg/ml Kenalog mg/ml 10 mg/ml 5-12
13 7 1 13
,
23 3 23 3 15 3.7 21 44,612 22 46,28 3.4 21 1,185 22 1,53 9,283 2 4,435 6 8.1 21 35,956 22 38,864 67.1 21 379 22 633 12,745 2.6 1.1 No.84 15 6 24 1 11 1 21 22 3.2 1.4 2291 22 4 2 5 15 1 6 5 1998 1999 11
●70974_100_AC009160_KAPヘ<3099>ーシス自動車約款（11.10）.indb
" # $ % & ' ( ) * +, -. / 0 1 2 3 4 5 6 7 8 9 : ; < = >? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y " # $ % & ' ( ) * + , -. / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B
- 1 - - 2 - 320 421 928 1115 12 8 116 124 2 7 4 5 428 515 530 624 921 1115 1-3 - 100 250-4 - - 5 - - 6 - - 7 - - 8 - - 9 - & & - 11 - - 12 - GT GT - 13 - GT - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - -
2
1 2 119 119 5 500 1 30 102 1 113 3 4 120 2 3 113 5 230 1 1 3 4 5 6 7 8 1 support@kansen.sakura.ne.jp 2 9 3 ( ) 10 11 12 4 1. 2. 3. 4. 13 5 14 15 16 17 18 19 [ ] [ ] 20 [ ] [ ] [ ] 21 22 [ ] 23 < > < >
1
1 2 3 4 5 6 7 8 9 ヒアリング 10 11 ➊ ➋ ➌ 12 13 ➊ ➋ 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ハイエンドホテルバジェットホテル ➊ ➋ ➌ 29 30 31 32 33 34 35 36 37 38 39 40 United States : China United Kingdom Spain Thailand
EL-G37
EL-G37 A A A A A A A A A A A A A A GT F543210A CE CA 4 00. 00 23.80 2 015.6250 77.14286 96. 91. 102. 25. 9. 1 700. 2 720. 2.5 7. 20. 25. 220. 400. 4 096. 4.685 0.084 M 125. M 28. M 85.
Taro9-医薬品目次２０１２－１.PDF
5 0.1% 11 250mg 10 20mg 10 5ml 19 0.05% 13 1.25mg 10 1%5ml 19 10mg 10 0.2%100ml 18 25%50ml 9 2mg 17 5%250ml 9 20%25g 20 500 g 11 4 10g 20 Cap150mg 1 200mg 0 Cap90mg 5 20mg 10 10% 5 18 10mg 10 3%30g 20
A5_Catalog-US-JN_ indd
66 22 g 13 g 8 g 5 g 7500 IU 150% 300 mg 600 IU 100 IU 80 mcg 3 mg 3.5 mg 40 mg 4 mg 500 mcg 12 mcg 300 mcg 20 mg 1000 mg 150 mcg 400 mg 15 mg 105 mcg 2 mg 2 mg 180 mcg 125 mcg 15 mg 3.6 g ** 3.8 g **
... 3... 3... 3... 3... 4... 7... 10... 10... 11... 12... 12... 13... 14... 15... 18... 19... 20... 22... 22... 23 2
1 ... 3... 3... 3... 3... 4... 7... 10... 10... 11... 12... 12... 13... 14... 15... 18... 19... 20... 22... 22... 23 2 3 4 5 6 7 8 9 Excel2007 10 Excel2007 11 12 13 - 14 15 16 17 18 19 20 21 22 Excel2007
14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0
untitled
CA 04 1,360 100.8 0.1 83 34,176 7.61 0.40 51,532 1.3 322,736 5.9 05 1,369 100.0 0.8 80 57,269 7.86 0.43 55,001 6.7 311,107 3.6 06 1,370 99.8 0.2 83 48,250 7.73 0.46 56,369 2.5 319,129 2.6 06/ 1-3 99.4
近畿中国四国農業研究センター研究報告 第７号
230 C B A D E 50m 558 0 1km (mg L 1 ) T N NO 2 3 N NH 4 N 2.0 0 (a) 2001 1.5 6 20 21 5 1.0 0.5 0.0 2.0 1.5 1.0 0.5 0.0 14:00 17:00 (b) 2001 7 3 4 20:00 23:00 2:00 (h) 5:00 8:00 11:00 10 0 5 10 15
http://banso.cocolog-nifty.com/ 100 100 250 5 1 1 http://www.banso.com/ 2009 5 2 10 http://www.banso.com/ 2009 5 2 http://www.banso.com/ 2009 5 2 http://www.banso.com/ < /> < /> / http://www.banso.com/
029 Meg D. Newman Meg D. Newman, MD.: New Developments in HIV Care for Women. From the AIDS Education, the UCSF Positive Health Program, San Francisco General Hospital Medical Center, 995 Potrero Ave c/o
１
Jetro technology bulletin-2005/12 477 2005/12, No.477...1...2 1....2 1-1....2 1-2...3 1-3...5 2....6 3....7 3-1...7 3-2...8 3-3...8 4....8 4-1...8 4-2...9 4-3...9 5....11...12 1....12 2....15 2-1...15
untitled
. 23 3 2 1 2 3 21 21 22 9 1 23 18 4 5 6 5 40 20 7 1 1 8 9 10 11 12 50cm 13 10 11 14 2011 3 11 15 16 ml mm tel 079-557-0039 & fax 079-557-1888 17 248-240- 98-48- 170-98- 98- ml 85-1,085-18 19 20 21 22 23
Microsoft Word - 表紙資料２－４
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
untitled
Loyalty Insights ネット プロモーター経営 ロブ マーキー フレッド ライクヘルド 森光威文 Copyright 2014 Bain & Company, Inc. All rights reserved. 1 NPS blog report fin NPS blog report fin 2 3 NPS blog report fin 4 NPS blog report fin NPS
n=360 28.6% 34.4% 36.9% n=360 2.5% 17.8% 19.2% n=64 0.8% 0.3% n=69 1.7% 3.6% 0.6% 1.4% 1.9% < > n=218 1.4% 5.6% 3.1% 60.6% 0.6% 6.9% 10.8% 6.4% 10.3% 33.1% 1.4% 3.6% 1.1% 0.0% 3.1% n=360 0% 50%
![かんたん操作ガイド[arrows M02]](/thumbs/39/20071242.jpg "かんたん操作ガイド[arrows M02]")
![かんたん操作ガイド[arrows RM02]](/thumbs/39/20475147.jpg "かんたん操作ガイド[arrows RM02]")
![かんたん操作ガイド[arrows M03]](/thumbs/42/22941141.jpg "かんたん操作ガイド[arrows M03]")
A-FR
11 12 > 17 13 14 http://store.uniqlo.com/jp/ http://www.uniqlo.com/jp/corp/customer 15 16 LONDON PARIS SHANGHAI 18 100 80 94 60 54 40 39 30 20 9 11 9 14 0 02 03 04 05 06 07 08 09 HONG KONG SEOUL NEW YORK
FR 34 316 13 303 54
FR 34 316 13 303 54 23 ( 1 14 ) ( 3 10 ) 8/4 8/ 100% 8 22 7 12 1 9 8 45 25 28 17 19 14 3/1 6/27 5000 8/4 12/2930 1 66 45 43 35 49 25 22 20 23 21 17 13 20 6 1 8 52 1 50 4 11 49 3/4/5 75 6/7/8 46 9/10/11
untitled
-- -- -3- % % % 6% % % 9 66 95 96 35 9 6 6 9 9 5 77 6 6 5 3 9 5 9 9 55 6 5 9 5 59 () 3 5 6 7 5 7 5 5 6 6 7 77 69 39 3 6 3 7 % % % 6% % % (: ) 6 65 79 7 3 36 33 9 9 5 6 7 3 5 3 -- 3 5 6 76 7 77 3 9 6 5
untitled
NO. 2007 10 10 34 10 10 0570-058-669 http://www.i-nouryoku.com/index.html (40 ) () 1 NO. 2007 10 10 2.2 2.2 130 70 20 80 30 () () 9 10 () 78 8 9 () 2 NO. 2007 10 10 4 7 3 NO. 2007 10 10 40 20 50 2 4 NO.
Supplier Open Balance Vision Operations Tuesday, February 03, 2004 Advanced Network Devices 2000 Century Way,, Santa Clara, CA, US お客様各位 Fe
Advanced Network Devices 2000 Century Way,, Santa Clara, CA, 95613-4565 今回合計御請求額 500 FRF の詳細は以下のようになっております 伝票 No. 日付タイプ金額御請求額 123 20-JAN-98 Standard 500.00 500.00 小計 : 500.00 500.00 今回合計御請求額 : 500.00 500.00
32 1 7 1 20 ( ) [18 30] [21 00] 2 3 ( ( ) ) ( ) 4 1 2 95 ( 7 3 2 ) 1 2 3 2 a b
![32 1 7 1 20 ( ) [18 30] [21 00] 2 3 ( ( ) ) ( ) 4 1 2 95 ( 7 3 2 ) 1 2 3 2 a b](/thumbs/41/22465094.jpg "32 1 7 1 20 ( ) [18 30] [21 00] 2 3 ( ( ) ) ( ) 4 1 2 95 ( 7 3 2 ) 1 2 3 2 a b")
31 1 7 1 ( ) [18 35] [20 40] 2 3 ( ( ) ) ( ) 4 1 2 1 22 1 2 a b T T A c d 32 1 7 1 20 ( ) [18 30] [21 00] 2 3 ( ( ) ) ( ) 4 1 2 95 ( 7 3 2 ) 1 2 3 2 a b 7 1 ( 34 ) 1 7 2 13 ( ) [18 20] [20 00] 2 4 7 3
1 2 3 6 10 < > 13 16 16 4 17 13 00 15 30 5
2004 16 3 23 q 4 21 r 1 2 3 6 10 < > 13 16 16 4 17 13 00 15 30 5 13 2 2 16 4 4 17 3 16 3 1 16 3 2 905 1438 1201 1205 1210 70 1812 25 1635 1654 3 44 47 10 10 911.18-R 1193 34 1652 4 911.107-H 1159 1685
項 目
1 1 2 3 11 4 6 5 7,000 2 120 1.3 4,000 04 450 < > 5 3 6 7 8 9 4 10 11 5 12 45 6 13 E. 7 B. C. 14 15 16 17 18 19 20 21 22 23 8 24 25 9 27 2 26 6 27 3 1 3 3 28 29 30 9 31 32 33 500 1 4000 0 2~3 10 10 34
prd-100731s001-20101026_1253(2).pdf
ISSN 1340-6671 POWER & ENERGY SYSTEM NEWSLETTER No.41 Nov 2010 POWER & ENERGY SYSTEM NEWSLETTER No.41 Nov 2010 POWER & ENERGY SYSTEM 200mm 300mm 450mm 650mm NEWSLETTER No.41 Nov 2010 Abstracts Submitted
......1201-P1.`5
2009. No356 2/ 5 6 a b b 7 d d 6 ca b dd a c b b d d c c a c b - a b G A bb - c a - d b c b c c d b F F G & 7 B C C E D B C F C B E B a ca b b c c d d c c d b c c d b c c d b d d d d - d d d b b c c b
I
I II 1 2 3 4 5 6 7 8 9 10 11 Rp.1) 50mg 3 3 14 Rp.2) 2.5mg 2 14 Rp.1) 2.5mg 3 2 2:1 14 Rp.) 15g 1 3 28 Rp.2) 50 600mg 1 2 28 12 Rp.1) CR 20mg 1 1 1 14 Rp.2) R 200 1 2 14 Rp.3) 3 1 3 14 Rp.1) 2.5mg 0.4
EPSON
B K L & & & & & & & & L & & & & & & & K & & & & & L L L & & & K L L L & & L L L & & & & & & & & & & & & & & & & & & & & & & & & & & & L & K L K & & & & & & & L L & & L & & L L & & & & &
2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1
2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1 16 24 21 20 20 23 10 11 9 10 3 3 3 2 3 1 3 4 6 8 2 0 1 2 3 4 5 6 0 1 2 3 4 5 6 0 1 2 3 4 5 6 3 4 Q & A Q1 A1 Q2 A2 Q3 A3 7
Q&A最低資本金特例030131.PDF
& 1 2 2 3 2 2 3 2 2 3 10 11 10 90 12 13 14 15 16 17 18 19 20 2 2 3 21 2 2 3 22 23 24 25 20 10 26 27 28 10 8 1 29 30 10 8 2 31 32 2 2 3 33 10 8 3 10 11 2 34 10 8 3 10 12 2 35 36 20 10 37 38 39 40 41 42
™…
2/10 15 2010. No1362 1 1 216315 91430 Q A & 0.23% 1 1.4% 04-7120-2020 050-5540-2023 Q A & 1 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 1 2 3 4 5 6 7 8 9 10
bumon_pro.indd
q w e r t y u i o!0 !1!2!3 !4!5!6 !7!8!9 @0 @1 @2 @3 @4 @5 @6 @7 @8 @9 #0 #1 #2 #3 #4 #5 #6 #7 #8 #0 $0 $1 $2 $3 $4 $5 $6 $7 $8 $9 %0 %1 %2 %3 %4 %5 %6 %7 %8 %9 ^0 ^1 ^2 ^3 ^4 ^5 ^6 ^7 ^8 ^9 &0 &1 &2
2012_10_A_cover.indd
c %& r Z \ W n % & & % % & % & & % % % & % & % & & % & % %& % & % & % % % & & & W W W W A
‡o‡P†C‡P‡Q”R„û†^‡P†C‡P‡Q
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Q & A ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2012_05_GLK_cover.indd
c %& r Z \ W W n q & F % % & & % & & % % % & % & % & % & % & % & F F % % % & & & & % & A
2013 London New York Paris 2013 Tokyo Singapore
01 London New York Paris 01 Tokyo Singapore 01 10 Global Power City Index GPCI 008 Global Power City Index GPCI-01 GPCI YEAR BOOK 01 Global Power City Index GPCI 1... 40 6 4 5 4. 5. Global Power City
1
1 5% 4% 11% 8% 13% 12% 10% 6% 17% 6% 8% 4% 6% 6% 2% 17% 17% 12% 14% 16% 6% 37% 11% 17% 35% 2 (N=6,239) 0 200 400 600 800 1,000 1,200 1,400 1,600 1,800 1,585 1,126 950 494 345 296 242 263 191 150 131 116
II a. 1 2 3 3 4 4 5 5 6 b. 6 7 7 8 8 9 10 11 9 10 11 1 2 b. 2 3 6 7 c. 4 8 5 6 9 7 8 10 9 10 11 1112 12 13 13 14 d. 14 15 15 16 423m 16 17 17 1 a. 2 1
II a b v w x y q c r u t s j k l m n h i g d e f o 1. 2. 3,776m 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. p 1. 5 2. 16 3. 6 4. 18 5. 20 6. 21 7. 22 8. 24 9. 25 10. 15 11. 19 12.
...j.N.. AR2005(.O..)
1984 expansion 1998 world 2001 2005 transformation FAST RETAILING CO., LTD. our group UNIQLO COMPTOIR DES COTONNIERS FOOT PARK ASPESI national standard Theory business model products Do you know?
untitled
280 200 5 7,800 6 8,600 28 1 1 18 7 8 2 ( 31 ) 7 42 2 / / / / / / / / / / 1 3 (1) 4 5 3 1 1 1 A B C D 6 (1) -----) (2) -- ()) (3) ----(). ()() () ( )( )( )( ) ( ) ( )( )( )( ) () (). () ()() 7 () ( ) 1
c a a ca c c% c11 c12
c a a ca c c% c11 c12 % s & % c13 c14 cc c16 c15 %s & % c211 c21% c212 c21% c213 c21% c214 c21% c215 c21% c216 c21% c23 & % c24 c25 c311 c311 % c% c % c312 %% a c31 c315 c32 c33 c34 % c35 c36 c411 c N
1 2 http://www.japan-shop.jp/ 3 4 http://www.japan-shop.jp/ 5 6 http://www.japan-shop.jp/ 7 2,930mm 2,700 mm 2,950mm 2,930mm 2,950mm 2,700mm 2,930mm 2,950mm 2,700mm 8 http://www.japan-shop.jp/ 9 10 http://www.japan-shop.jp/
第18回海岸シンポジウム報告書
2011.6.25 2011.6.26 L1 2011.6.27 L2 2011.7.6 2011.12.7 2011.10-12 2011.9-10 2012.3.9 23 2012.4, 2013.8.30 2012.6.13 2013.9 2011.7-2011.12-2012.4 2011.12.27 2013.9 1m30 1 2 3 4 5 6 m 5.0m 2.0m -5.0m 1.0m
